Make an appointment with a cancer specialist today.
Call us at 800-KARMANOS (800-527-6266)


Dr. Andre Konski to lead working group focusing on lessening pain of cancer treatment

 Andre Konski, M.D., M.B.A., M.A., F.A.C.R.,

Andre Konski, M.D., M.B.A., M.A., F.A.C.R., service chief for Radiation Oncology at Karmanos Cancer Center and chair of the Department of Radiation Oncology for Wayne State University School of Medicine, has been named to head the Late Effects and Survivors Working Group of the Radiation Therapy Oncology Group.

“It is an honor to be chosen along with my friend and colleague, Dr. Charles Scarantino from the University of North Carolina, Rex Cancer Center, to lead the RTOG’s effort in investigating ways to lessen the burden of cancer treatment for patients and their families,” said Dr. Konski, who is also a member of the Wayne State University Physician Group.

A member of the RTOG for about 15 years, Dr. Konski also chairs the group’s Economic Subcommittee and is a member of the Research Strategy Committee and the Health Services Research and Outcomes Steering Committee.

He was selected to head this new group because of his interests in late effects and survivor issues. The group was formed, Dr. Konski said, to investigate factors that lead to the development of late effects in cancer patients receiving radiation treatment.

“Once those factors are identified, interventions can be developed to reduce the burden of the late effects,” he said.

As the co-leader of the new work group, Dr. Konski said he would like to see the body identify factors leading to the development of second malignant tumors after patients receive radiotherapy.

Formed in 1968, the Radiation Therapy Oncology Group is a leader in working to increase survival and improve the quality of life for cancer patients. The group is a clinical research component of the American College of Radiology and serves as a multi-institutional, international clinical cooperative group funded primarily by the National Cancer Institute.
© 2014 Karmanos Cancer Institute Pencil
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.